Advocacy News

SITC Participates in Sign on Letter to Support the AKACA

By SITC Advocacy posted 12-11-2024
SITC has recently signed on to a letter from the Leukemia Lymphoma Society advocating congress to pass ...
0 comments
 
Cancer Research Policy User-Generated   Letter

SITC Hosts Tumor Biomarkers and Assessing PD-1: Increasing Access to IO Webinar

By SITC Advocacy posted 12-04-2024
This webinar on November 21st examined how biomarkers are used to define “PD-L1” positive patients around ...
0 comments
 
Cancer Research Policy Modality Webinar

Annual Meeting Session Highlight: Cellular Therapies/Regulatory/Manufacturing

By SITC Advocacy posted 11-06-2024
Cellular therapies offer great promise as a cancer therapy. They are living biological drugs, and often ...
0 comments
 
User-Generated   SITC2024

Tumor Infiltrating Lymphocytes (TIL) Symposium

By SITC Advocacy posted 11-04-2024
As part of the 39th Annual Meeting & Pre-Conference Programs (SITC 2024), the SITC Tumor Infiltrating ...
0 comments
 
User-Generated   SITC2024

SITC Hosts Monitoring Response to Cancer Immunotherapy: Increasing Access to IO Webinar

By SITC Advocacy posted 10-30-2024
This webinar on October 16th examined the importance of monitoring response to cancer immunotherapy, ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC Hosts Rationalized Patient Match and Clinical Trial Design with Large/Moderate Language Models on EHR Data: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 10-23-2024
Thousands of IO clinical trials are currently available to cancer patients, all of which are aiming to ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Hosts Rare and Challenging Cases: Increasing Access to IO Webinar

By SITC Advocacy posted 10-09-2024
This webinar on September 26th examined how rare and challenging cases, such as extremes of age, immunocompromised, ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC Hosts Predicting Drug Resistance and Drug Repurposing with Imaging-Based AI: AI in Immuno-oncology Webinar

By SITC Advocacy posted 10-02-2024
Increased understanding of immunotherapy mechanisms of action may enhance researchers’ ability to circumvent ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Comments on FDA Guidance

By SITC Advocacy posted 09-26-2024
SITC has provided comment on the recently posted "Diversity Action Plans to Improve Enrollment of Participants ...
0 comments
 
Cancer Research Policy User-Generated   FDA

SITC Hosts Predicting Early Diagnosis and Response with Multimodal AI: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 09-16-2024
Earlier cancer diagnosis, as well as rapid determination of tumor response after treatment, could lead ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Hosts Immune Checkpoint Inhibitors: Increasing Access to IO Webinar

By SITC Advocacy posted 08-21-2024
This webinar on August 15th examined how immune checkpoint inhibitors are being utilized around the globe ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC Hosts Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncology Webinar

By SITC Advocacy posted 08-06-2024
Social determinants of health are becoming increasingly understood as having significant impact in immunotherapy ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

Crisis in Clinical Research, a Commentary

By SITC Advocacy posted 07-22-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a commentary ...
0 comments
 
Cancer Research Policy User-Generated   Crisis   JITC

SITC Hosts Cell Therapy Administration: Increasing Access to IO Webinar

By SITC Advocacy posted 07-17-2024
This webinar on July 10th examined how cell therapies are being utilized around the globe and in resource ...
0 comments
 
Cancer Research Policy Modality Webinar

Call for Comment - Surrogate Endpoints Virtual Summit Executive Summary

By SITC Advocacy posted 07-12-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a comprehensive ...
0 comments
 
Cancer Research Policy

SITC Hosts Opportunities and Implications for IO Using AI and Digital Pathology: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 06-27-2024
Digital pathology is becoming an increasingly important technique for immunotherapy drug development ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Hosts The Current Landscape of IO Access: Increasing Access to IO Webinar

By SITC Advocacy posted 06-12-2024
This webinar on June 5th reviewed effective strategies for cancer immunotherapy administration by providing ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   Global

SITC Hosts AI in Personalized Immunotherapies: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 05-22-2024
The vision of personalized medicine based on tumor-specific biomarkers comes closer to reality with each ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Hosts Real-Time AI Monitoring & Early Detection of Immune-Related Adverse Events: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 05-09-2024
AI is being investigated for real-time monitoring of patients receiving immunotherapy for immune-related ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC In-Person on the Hill 2024 - Thank You Dr. Sullivan

By SITC Advocacy posted 05-01-2024
SITC thanks Policy Committee chair Dr. Ryan Sullivan and many other SITC members for assisting with this ...
0 comments
 
Cancer Research Policy User-Generated   SITContheHill